Amphastar P (AMPH)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.25B
Last updated: Nov 17, 2026 at 11:05 AM ET
Amphastar P (AMPH) Financials: Revenue, Profit and Cash Flow
Amphastar P reported revenue of $719.89M for the fiscal year ended Dec 31, 2025, down 1.7% from the year before. That year, net income was $98.09M with a net margin of 13.6%, operating cash flow was $156.12M and free cash flow was $121.23M. The quarter ended Sep 30, 2026 had revenue of $207.61M and net income of $37.76M.
Revenue and Margins
The operating margin was 19.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $255.16M, a compound annual rate of 12.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $719.89M | -1.7% | 49.5% | 19.5% | 13.6% |
| Dec 2024 | $731.97M | +13.6% | 51.1% | 28.1% | 21.8% |
| Dec 2023 | $644.39M | +29.1% | 54.5% | 30.6% | 21.3% |
| Dec 2022 | $498.99M | +14.0% | 49.9% | 21.5% | 18.3% |
| Dec 2021 | $437.77M | +25.1% | 45.6% | 16.0% | 14.5% |
| Dec 2020 | $349.85M | +8.5% | 41.0% | 3.1% | 0.3% |
| Dec 2019 | $322.36M | +9.4% | 40.9% | 0.0% | 14.4% |
| Dec 2018 | $294.67M | +22.7% | 36.3% | -2.9% | -2.3% |
| Dec 2017 | $240.18M | -5.9% | 37.7% | -0.5% | 1.5% |
| Dec 2016 | $255.16M | N/A | 40.8% | 6.0% | 3.8% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 38.5% from the year before. In the quarter ended Sep 2026, net income rose 117.6% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $719.89M | $731.97M | $644.39M | $498.99M | $437.77M | $349.85M | $322.36M | $294.67M | $240.18M | $255.16M |
| Cost of revenue | $363.83M | $358.11M | $293.27M | $250.13M | $238.03M | $206.51M | $190.43M | $187.68M | $149.67M | $150.97M |
| Gross profit | $356.06M | $373.86M | $351.12M | $248.86M | $199.74M | $143.34M | $131.92M | $106.98M | $90.51M | $104.20M |
| Research and development | $85.84M | $73.91M | $73.74M | $74.77M | $60.93M | $67.23M | $68.85M | $57.56M | $43.50M | $41.52M |
| Operating income | $140.40M | $205.42M | $196.99M | $107.50M | $69.89M | $10.95M | -$39.00K | -$8.62M | -$1.27M | $15.38M |
| Net income | $98.09M | $159.52M | $137.54M | $91.39M | $63.30M | $1.10M | $46.51M | -$6.66M | $3.65M | $9.82M |
| EBITDA | $206.98M | $272.73M | $246.23M | $145.31M | $111.17M | $29.55M | $80.47M | $6.38M | $17.46M | $30.06M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $207.61M | $183.90M | $171.17M | $183.10M | $191.84M | $174.41M | $170.53M | $186.52M | $191.21M | $182.39M | $171.84M | $178.10M |
| Gross profit | $99.63M | $93.47M | $70.32M | $85.67M | $98.65M | $86.49M | $85.25M | $86.65M | $101.94M | $95.17M | $90.10M | $96.14M |
| Operating income | $50.77M | $39.73M | $13.63M | $35.61M | $25.32M | $42.18M | $37.29M | $45.14M | $57.05M | $55.22M | $48.01M | $53.98M |
| Net income | $37.76M | $30.35M | $6.42M | $24.43M | $17.35M | $31.03M | $25.29M | $37.96M | $40.43M | $37.95M | $43.18M | $36.17M |
Balance Sheet
As of Dec 2025, total debt of $610.39M exceeded cash and equivalents by $440.21M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.63B | $1.58B | $1.51B | $741.99M | $671.53M | $631.24M | $586.97M | $513.56M | $451.07M | $427.74M |
| Current assets | $636.02M | $534.07M | $489.60M | $378.32M | $318.12M | $279.68M | $255.24M | $220.34M | $187.78M | $184.10M |
| Cash and equivalents | $170.18M | $151.61M | $144.30M | $156.10M | $126.35M | $92.64M | $73.69M | $86.34M | $65.59M | $72.35M |
| Total liabilities | $840.49M | $845.17M | $873.49M | $213.33M | $226.01M | $182.51M | $159.44M | $149.20M | $117.34M | $98.48M |
| Short-term debt | $1.64M | $234.00K | $436.00K | $3.05M | $2.20M | $12.26M | $7.74M | $18.23M | $6.31M | $5.37M |
| Long-term debt | $608.75M | $601.63M | $589.58M | $72.84M | $74.78M | $34.19M | $39.39M | $31.98M | $40.84M | $32.36M |
| Shareholder equity | $788.80M | $732.30M | $639.42M | $528.66M | $445.52M | $402.31M | $381.37M | $332.44M | $333.74M | $329.25M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.71B | $1.74B | $1.65B | $1.63B | $1.67B | $1.62B | $1.63B | $1.58B | $1.55B | $1.49B | $1.57B | $1.51B |
| Total liabilities | $897.17M | $975.61M | $874.77M | $840.49M | $889.48M | $857.85M | $874.99M | $845.17M | $817.50M | $778.18M | $901.96M | $873.49M |
| Cash and equivalents | $204.59M | $223.61M | $170.94M | $170.18M | $216.26M | $187.69M | $182.78M | $151.61M | $192.12M | $189.62M | $201.15M | $144.30M |
| Shareholder equity | $814.55M | $768.16M | $773.39M | $788.80M | $776.75M | $757.48M | $751.28M | $732.30M | $727.68M | $713.35M | $672.36M | $639.42M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 77.7% of operating cash flow. Share repurchases came to 62.4% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $156.12M | $213.39M | $183.50M | $89.18M | $97.99M | $57.27M | $41.76M | $38.19M | $39.21M | $38.56M |
| Capital expenditures | $34.88M | $41.04M | $38.17M | $24.03M | $27.46M | $33.85M | $41.55M | $46.81M | $35.10M | $21.38M |
| Free cash flow | $121.23M | $172.34M | $145.34M | $65.15M | $70.54M | $23.41M | $207.00K | -$8.62M | $4.11M | $17.18M |
| Dividends paid | N/A | N/A | $454.09M | $15.66M | $15.93M | $23.16M | N/A | $20.31M | $0 | $10.20M |
| Share repurchases | $75.59M | $85.46M | $58.14M | $39.91M | $28.87M | $24.43M | $22.29M | $25.05M | $30.75M | $9.91M |
| Investing cash flow | -$70.33M | -$124.93M | -$649.12M | -$32.78M | -$28.67M | -$36.41M | -$50.53M | -$42.18M | -$36.89M | -$39.50M |
| Financing cash flow | -$67.42M | -$80.95M | $454.09M | -$26.44M | -$37.02M | -$2.25M | -$3.78M | $25.01M | -$7.72M | $7.14M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $43.30M | $51.32M | $47.84M | $32.86M | $52.58M | $35.59M | $35.08M | $29.02M | $59.96M | $69.11M | $55.29M | $23.86M |
| Capital expenditures | $9.94M | $8.59M | $9.51M | $8.27M | $5.35M | $10.56M | $10.70M | $12.41M | $13.79M | $6.04M | $8.79M | $9.44M |
| Free cash flow | $33.36M | $42.73M | $38.33M | $24.59M | $47.23M | $25.03M | $24.38M | $16.61M | $46.17M | $63.06M | $46.50M | $14.42M |
Frequently Asked Questions About AMPH
What is Amphastar P's annual revenue?
Amphastar P reported revenue of $719.89M for the fiscal year ended Dec 31, 2025.
How fast is Amphastar P's revenue growing?
Revenue was down 1.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 13.0%.
Is Amphastar P profitable?
Yes. Amphastar P reported net income of $98.09M for the fiscal year ended Dec 31, 2025, with a net margin of 13.6%.
How much free cash flow does AMPH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $156.12M minus capital expenditures of $34.88M produced free cash flow of $121.23M.
How much debt does Amphastar P have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $608.75M, short-term debt of $1.64M and cash and equivalents of $170.18M.
AMPH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors